KEGG   ORTHOLOGY: K09389
Entry
K09389                      KO                                     

Name
E2F2
Definition
transcription factor E2F2
Pathway
ko01522  Endocrine resistance
ko04110  Cell cycle
ko04218  Cellular senescence
ko04934  Cushing syndrome
ko05160  Hepatitis C
ko05161  Hepatitis B
ko05163  Human cytomegalovirus infection
ko05166  Human T-cell leukemia virus 1 infection
ko05167  Kaposi sarcoma-associated herpesvirus infection
ko05169  Epstein-Barr virus infection
ko05200  Pathways in cancer
ko05206  MicroRNAs in cancer
ko05212  Pancreatic cancer
ko05214  Glioma
ko05215  Prostate cancer
ko05218  Melanoma
ko05219  Bladder cancer
ko05220  Chronic myeloid leukemia
ko05222  Small cell lung cancer
ko05223  Non-small cell lung cancer
ko05224  Breast cancer
ko05225  Hepatocellular carcinoma
ko05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    K09389  E2F2; transcription factor E2F2
   04218 Cellular senescence
    K09389  E2F2; transcription factor E2F2
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K09389  E2F2; transcription factor E2F2
   05206 MicroRNAs in cancer
    K09389  E2F2; transcription factor E2F2
  09162 Cancer: specific types
   05212 Pancreatic cancer
    K09389  E2F2; transcription factor E2F2
   05225 Hepatocellular carcinoma
    K09389  E2F2; transcription factor E2F2
   05226 Gastric cancer
    K09389  E2F2; transcription factor E2F2
   05214 Glioma
    K09389  E2F2; transcription factor E2F2
   05220 Chronic myeloid leukemia
    K09389  E2F2; transcription factor E2F2
   05218 Melanoma
    K09389  E2F2; transcription factor E2F2
   05219 Bladder cancer
    K09389  E2F2; transcription factor E2F2
   05215 Prostate cancer
    K09389  E2F2; transcription factor E2F2
   05224 Breast cancer
    K09389  E2F2; transcription factor E2F2
   05222 Small cell lung cancer
    K09389  E2F2; transcription factor E2F2
   05223 Non-small cell lung cancer
    K09389  E2F2; transcription factor E2F2
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    K09389  E2F2; transcription factor E2F2
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K09389  E2F2; transcription factor E2F2
   05161 Hepatitis B
    K09389  E2F2; transcription factor E2F2
   05160 Hepatitis C
    K09389  E2F2; transcription factor E2F2
   05163 Human cytomegalovirus infection
    K09389  E2F2; transcription factor E2F2
   05167 Kaposi sarcoma-associated herpesvirus infection
    K09389  E2F2; transcription factor E2F2
   05169 Epstein-Barr virus infection
    K09389  E2F2; transcription factor E2F2
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K09389  E2F2; transcription factor E2F2
 09180 Brite Hierarchies
  09182 Protein families: genetic information processing
   03000 Transcription factors
    K09389  E2F2; transcription factor E2F2
Transcription factors [BR:ko03000]
 Eukaryotic type
  Helix-turn-helix
   Fork head/winged helix cell cycle-controlling factors, E2F
    K09389  E2F2; transcription factor E2F2
Genes
HSA: 1870(E2F2)
PTR: 469153(E2F2)
PPS: 100984393(E2F2)
PON: 100458002(E2F2)
NLE: 100583853(E2F2)
MCC: 710200(E2F2)
MCF: 102128093(E2F2)
CSAB: 103225395(E2F2)
RRO: 104656129(E2F2)
RBB: 108538448(E2F2)
CJC: 100414776(E2F2)
SBQ: 101042612(E2F2)
MMU: 242705(E2f2)
MCAL: 110293508(E2f2)
MPAH: 110323461(E2f2)
RNO: 684111(E2f2)
MUN: 110545385(E2f2)
CGE: 100754522(E2f2)
NGI: 103746411(E2f2)
HGL: 101711793(E2f2)
CCAN: 109693815 109693824(E2f2)
OCU: 100346379(E2F2)
TUP: 102479669(E2F2)
CFA: 100855664(E2F2)
VVP: 112930133(E2F2)
AML: 100475779(E2F2)
UMR: 103666789(E2F2)
UAH: 113268523(E2F2)
ORO: 101368301(E2F2)
ELK: 111154729
FCA: 101098067(E2F2)
PTG: 102952251(E2F2)
PPAD: 109274297(E2F2)
AJU: 106977597(E2F2)
BTA: 617024(E2F2)
BOM: 102268181(E2F2)
BIU: 109576116(E2F2)
BBUB: 102403332(E2F2)
CHX: 102186169(E2F2)
OAS: 105606975(E2F2)
SSC: 110261113(E2F2)
CFR: 102515523(E2F2)
CDK: 105088895(E2F2)
BACU: 103017714(E2F2)
LVE: 103081780(E2F2)
OOR: 101286856(E2F2)
DLE: 111163373(E2F2)
PCAD: 102996979
ECB: 100057866(E2F2)
EPZ: 103551301(E2F2)
EAI: 106839983(E2F2)
MYB: 102256714(E2F2)
MYD: 102755439(E2F2)
MNA: 107538329(E2F2)
HAI: 109386699(E2F2)
DRO: 112298997(E2F2)
PALE: 102884459(E2F2)
RAY: 107501037(E2F2)
MJV: 108401353(E2F2)
LAV: 100665816(E2F2)
TMU: 101357556
MDO: 100009746(E2F2)
SHR: 100921594(E2F2)
PCW: 110206051(E2F2)
OAA: 100085053(E2F2)
GGA: 425366(E2F2)
MGP: 100548112(E2F2)
CJO: 107324074(E2F2)
NMEL: 110387486(E2F2)
APLA: 113839791(E2F2)
ACYG: 106045119
TGU: 100223834(E2F2)
LSR: 110472901(E2F2)
SCAN: 103823540
GFR: 102036661(E2F2)
FAB: 101805813(E2F2)
PHI: 102101185(E2F2)
PMAJ: 107214004(E2F2)
CCAE: 111939061
CCW: 104694725
ETL: 114068404(E2F2)
FPG: 101913554(E2F2)
FCH: 102058355(E2F2)
CLV: 102094947(E2F2)
EGZ: 104132520(E2F2)
NNI: 104017698
ACUN: 113488364(E2F2)
AAM: 106486140(E2F2)
ASN: 102375233(E2F2)
AMJ: 109283792(E2F2)
PSS: 102453459(E2F2)
CMY: 102936830(E2F2)
CPIC: 101939699(E2F2)
ACS: 100553413
PVT: 110086160
PBI: 103055008(E2F2)
PMUR: 107302908(E2F2)
TSR: 106552942
PMUA: 114601481(E2F2)
GJA: 107109576(E2F2)
DRE: 568846(si:ch211-160f23.5)
CCAR: 109064982
IPU: 108270354(e2f2)
PHYP: 113544992(e2f2)
AMEX: 103027354
EEE: 113572001
TRU: 101072097(e2f2)
LCO: 104940402(e2f2)
NCC: 104956987(e2f2)
MZE: 101474527(e2f2)
ONL: 100691560(e2f2)
OLA: 101169156(e2f2)
XMA: 102228415(e2f2)
XCO: 114134222(e2f2)
PRET: 103458855(e2f2)
CVG: 107088043(e2f2)
NFU: 107392211(e2f2)
KMR: 108237131(e2f2)
ALIM: 106522405(e2f2)
AOCE: 111573342(e2f2)
CSEM: 103378649(e2f2)
POV: 109628156(e2f2)
LCF: 108875024
SDU: 111225590(e2f2)
SLAL: 111655894(e2f2)
HCQ: 109517212(e2f2)
BPEC: 110172062
MALB: 109955221(e2f2)
SALP: 111968929 112080445(e2f2)
ELS: 105006542(e2f2)
SFM: 108938635(e2f2)
PKI: 111859627(e2f2)
LCM: 102353099(E2F2)
CMK: 103179524
RTP: 109929351
AME: 412770
BIM: 100741567
BTER: 100647151
CCAL: 108629580
OBB: 114880933
SOC: 105203774
MPHA: 105831652
AEC: 105153819
ACEP: 105624414
PBAR: 105423207
VEM: 105560358
HST: 105184549
DQU: 106742780
CFO: 105252305
PGC: 109857267
OBO: 105286649
PCF: 106788716
NVI: 100123437
CSOL: 105362866
MDL: 103575408
TCA: 656396
DPA: 109542741
ATD: 109602516
NVL: 108569396
BMOR: 100216494(E2f1)
BMAN: 114250266
PMAC: 106707875
PRAP: 110995274
HAW: 110371803
TNL: 113492891
PXY: 105381100
API: 100163786
DNX: 107167183
AGS: 114128200
RMD: 113552257
BTAB: 109042413
ZNE: 110828766
FCD: 110843070
PVM: 113815959
PTEP: 107453668
HMG: 100201375
 » show all
Reference
PMID:8246995
  Authors
Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC
  Title
Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F.
  Journal
Mol Cell Biol 13:7802-12 (1993)
DOI:10.1128/MCB.13.12.7802
  Sequence
[hsa:1870]
LinkDB

DBGET integrated database retrieval system